Skip to main content
WAKAMOTO PHARMACEUTICAL CO.,LTD. logo

WAKAMOTO PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4512 ISIN · JP3991200001 T Manufacturing
Open in API
Filings indexed 59 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country JP Japan
Listing T 4512

About WAKAMOTO PHARMACEUTICAL CO.,LTD.

https://www.wakamoto-pharm.co.jp/englis…

WAKAMOTO PHARMACEUTICAL CO., LTD. is a company engaged in the research, development, production, and sale of pharmaceuticals. Its business encompasses both ethical (prescription) drugs and over-the-counter (OTC) products, as well as medical devices and health foods. The company specializes in therapeutic areas such as gastroenterology and is known as a pioneer in self-medication, with its flagship product being the nutrient-rich gastrointestinal remedy, "WAKAMOTO". The company actively manages a drug pipeline and engages in clinical trials to bring new therapeutic solutions to market.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 131
2025-11-13 Japanese
半期報告書－第131期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Wakamoto Pharmaceutical Co., Ltd. with the Kanto Local Finance Bureau. It contains comprehensive financial statements, including the balance sheet and income statement for the interim period ending September 30, 2025, as well as management analysis (MDA) and corporate information. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H1 2026
2025-11-13 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being submitted because resolutions were passed at the Annual General Meeting (AGM) held on June 24, 2025, in accordance with financial instruments regulations. Section 2 details the resolutions passed, including the approval of the dividend proposal and the election/re-election of directors, as well as the voting results (votes for, against, abstentions). This content perfectly matches the definition of reporting the official results from a shareholder vote at a general meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-06-27 Japanese
内部統制報告書－第130期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the cover page and throughout the text. It references the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項), which mandates the filing of an Internal Control Report in Japan. The content discusses the framework, scope, criteria, and conclusion regarding the effectiveness of internal controls over financial reporting as of the fiscal year-end (March 31, 2025). This directly corresponds to the definition of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although this specific document focuses purely on internal controls over financial reporting, which is a key component often filed alongside or as part of the annual audit process in Japan (J-SOX). Given the specific nature of an 'Internal Control Report' focusing on the effectiveness of controls over financial reporting, 'AR' (Audit Report / Information) is the most appropriate classification among the provided options, as it covers reports related to internal/regulatory testing and accounting principles, distinct from the full 10-K or a simple earnings release.
2025-06-20 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document text contains Japanese characters and includes the header "有価証券報告書（通常方式）" which translates to "Securities Report (Normal Method)". It also explicitly mentions the submission date, company name, and confirms the appropriateness of the contents of the Securities Report for the fiscal year ending March 31, 2025, based on the Financial Instruments and Exchange Act. A comprehensive Securities Report filed annually in Japan is equivalent to the US 10-K filing. Although the document itself appears to be a confirmation statement ('確認書') related to the Securities Report, the core subject matter and context point directly to the Annual Report filing. Given the options, the closest and most appropriate classification for a document confirming the contents of a full annual securities report is the Annual Report (10-K). If a specific confirmation document code existed, it would be used, but 10-K represents the underlying annual filing being confirmed. FY 2025
2025-06-20 Japanese
有価証券報告書－第130期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Securities Report), which is the standard annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial data, business information, and management analysis for the fiscal year ending March 31, 2025. This corresponds to the definition of an Annual Report (10-K equivalent). FY 2025
2025-06-20 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.